Zoetis Inc. (ZTS): Price and Financial Metrics

Zoetis Inc. (ZTS): $164.84

1.32 (+0.81%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

B

ZTS Price/Volume Stats

Current price $164.84 52-week high $200.53
Prev. close $163.52 52-week low $144.80
Day low $163.53 Volume 6,220,100
Day high $166.39 Avg. volume 2,552,320
50-day MA $178.77 Dividend yield 1.06%
200-day MA $176.65 Market Cap 74.37B

ZTS Stock Price Chart Interactive Chart >


Zoetis Inc. (ZTS) Company Bio


Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. (Source:Wikipedia)


ZTS Latest News Stream


Event/Time News Detail
Loading, please wait...

ZTS Latest Social Stream


Loading social stream, please wait...

View Full ZTS Social Stream

ZTS Price Returns

1-mo -6.85%
3-mo -14.65%
6-mo -1.40%
1-year -14.62%
3-year -30.22%
5-year 28.75%
YTD -15.65%
2023 35.91%
2022 -39.51%
2021 48.26%
2020 25.76%
2019 55.71%

ZTS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ZTS Dividend History

Continue Researching ZTS

Here are a few links from around the web to help you further your research on Zoetis Inc's stock as an investment opportunity:

Zoetis Inc (ZTS) Stock Price | Nasdaq
Zoetis Inc (ZTS) Stock Quote, History and News - Yahoo Finance
Zoetis Inc (ZTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!